Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Bifidobacterium animalis subsp. lactis BB-12 and Improved Immune Function

Research synthesisVery low evidenceMixed effect size4 studies · 4 beneficial · 0 neutral · 0 harmful

Across 4 review studies, all reported beneficial effects of Bifidobacterium animalis subsp. lactis BB-12 on immune function, with effect sizes ranging from small to large (mixed). The predominant evidence is qualitative, as no studies provided statistical significance data. No consistent dose or population data are available due to reporting gaps.

Caveats: Available evidence is overwhelmingly positive — clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed). Evidence base is small (only 4 studies) — conclusions should be considered preliminary. Many of the included studies did not reach statistical significance — effect may be smaller than the predominant direction suggests. All studies are reviews, not primary trials, which limits causal inference.

Generated Jul 11, 2026
4 of 4 papers
Back to top